Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants. Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants. Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants. Issues related to development, manufacture, and distribution of coronavirus vaccines; H.R. 2379 - State Opioid Response Grant Authorization Act of 2021 - reauthorizes and expands grant programs for State responses to the opioid use disorder crisis; H.R. 4341 and S. 987 - Comprehensive Addiction and Recovery Act of 2021 (CARA 3.0) Act of 2021 - entire bill reauthorizing and expanding treatment and recovery for substance abuse disorders, including Medicare coverage and state programs; H.R. 7681 - Preventing Overdoses and Saving Lives Act 2.0 - reauthorizes grants for emergency treatments to reverse opioid overdoses; H.R. 7900 - National Defense Authorization Act for Fiscal Year 2023 - provisions related to chemical and biological defense and access to Naloxone; H.R. 2617 - Consolidated Appropriations Act, 2023 - Division H - Department of Labor, Health and Human Services, and Education, and Related Agencies, Appropriations Act, 2023 - Title II Department of Health and Human Services - funding for development, acquisition, and stockpiling of medical countermeasures (MCM) for the U.S. Government, substance abuse treatments and State Opioid Response Grants.
HCR - Health Issues BUD - Budget/Appropriations DIS - Disaster Planning/Emergencies HOM - Homeland Security
2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE 2 - HOUSE OF REPRESENTATIVES 1 - SENATE
HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC
701 EIGHTH STREET, NW, SUITE 610, WASHINGTON, DC, 20001, US
THOMAS PAUL LATHAM FRANKLIN C PHIFER TIMOTHY P HECHT THOMAS PAUL LATHAM FRANKLIN C PHIFER TIMOTHY P HECHT THOMAS PAUL LATHAM FRANKLIN C PHIFER TIMOTHY P HECHT THOMAS PAUL LATHAM FRANKLIN C PHIFER TIMOTHY P HECHT